Advertisement

Other Allergic Conditions: Venom Hypersensitivity, Drug Allergy, Chronic Urticaria/Angioedema, and Primary Immune Deficiency

  • Brian Schroer
Chapter

Abstract

This chapter reviews miscellaneous but common topics seen by both primary care and specialty clinicians. It covers practical advice for adolescents who have had reactions to stinging insects, chronic urticaria, medication allergies, and concerns for immunodeficiency.

Keywords

Stinging insect allergy Medication allergy Chronic urticaria Angioedema Immunodeficiency 

References

  1. 1.
    Centers for Disease Control. The National Institute for Occupational Safety and Health (NIOSH) [Internet]. Insects and Scorpions [cited 2017 Sept 21]. Available from: https://www.cdc.gov/niosh/topics/insects/.
  2. 2.
    Mauriello PM, Barde SH, Georgitis JW, Reisman RE. Natural history of large local reactions from stinging insects. J Allergy Clin Immunol. 1984;74:494–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Golden DB, Moffitt J, Nicklas RA, Freeman T, Graft DF, Reisman RE, et al. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol. 2011;127:852–4.CrossRefPubMedGoogle Scholar
  4. 4.
    Nguyen SA, Napoli DC. Natural history of large local and generalized cutaneous reactions to imported fire ant stings in children. Ann Allergy Asthma Immunol. 2005;94:387–90.CrossRefPubMedGoogle Scholar
  5. 5.
    Walker R, Jacobs J, Tankersly M, Hagan L, Freeman T. Rush immunotherapy for the prevention of large local reactions secondary to imported fire ant stings. J Allergy Clin Immunol. 1999;103:S180.Google Scholar
  6. 6.
    Severino MG, Cortellini G, Bonadonna P, Francescato E, Panzini I, Macchia D, et al. Sublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind placebo-controlled trial. J Allergy Clin Immunol. 2008;122:44–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Centers for Disease Control. The National Institute for Occupational Safety and Health (NIOSH) [Internet]. Fast Facts [cited 2017 Sept 21]. Available from: https://www.cdc.gov/niosh/docs/2010-117/pdfs/2010-117.pdf.
  8. 8.
    Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med. 1978;299:157–61.CrossRefPubMedGoogle Scholar
  9. 9.
    Muller U, Thurnheer U, Patrizzi R, Spiess J, Hoigne R. Immunotherapy in bee sting hypersensitivity: bee venom versus wholebody extract. Allergy. 1979;34:369–78.CrossRefPubMedGoogle Scholar
  10. 10.
    Food Allergy Research Education. [Internet] Food allergy emergency care plan [cited 2017 Sept 21]. Available from: https://www.foodallergy.org/file/emergency-care-plan.pdf.
  11. 11.
    American Academy Allergy Asthma Immunology. [Internet] Anaphylaxis emergency care plan [cited 2017 Sept 21]. Available from: https://www.aaaai.org/aaaai/media/medialibrary/pdf%20documents/libraries/anaphylaxis-emergency-action-plan.pdf.
  12. 12.
    Wang J, Sicherer S. Guidance on completing a written allergy and anaphylaxis emergency plan. Pediatrics. 2017;139(3):e20164005.CrossRefPubMedGoogle Scholar
  13. 13.
    Allergy and Asthma Foundations of America. [Internet] Anaphylaxis emergency action plan [cited 2017 Sept 21]. Available from: http://www.aafa.org/media/Anaphylaxis-Emergency-Action-Plan.pdf.
  14. 14.
    Goldstein S, Gabriel S, Kianifard F, Ortiz B, Skoner DP. Clinical features of adolescents with chronic idiopathic or spontaneous urticaria: review of omalizumab clinical trials. Ann Allergy Asthma Immunol. 2017;118:500–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Mehregan DR, Hall MJ, Gibson LE. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol. 1992;26(3 Pt 2):441–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol. 2001;87:177–80.CrossRefPubMedGoogle Scholar
  17. 17.
    Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133:1270–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Tarbox JA, Gutta RC, Radojicic C, Lang DM. Utility of routine laboratory testing in management of chronic urticaria/angioedema. Ann Allergy Asthma Immunol. 2011;107:239–43.CrossRefPubMedGoogle Scholar
  19. 19.
    Kameyoshi Y, Tanaka T, Mihara S, Takahagi S, Niimi N, Hide M. Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients. Br J Dermatol. 2007;157(4):803.CrossRefPubMedGoogle Scholar
  20. 20.
    Richelson E. Tricyclic antidepressants and histamine H1 receptors. Mayo Clin Proc. 1979;54:669–74.PubMedGoogle Scholar
  21. 21.
    Kaplan A, Ledford D, Ashby M, Canvin J, Zazzali JL, Conner E, Veith J, Kamath N, Staubach P, Jakob T, Stirling RG, Kuna P, Berger W, Maurer M, Rosén K. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013;132:101–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Barniol C, Dehours E, Mallet J, Houze-Cerfon CH, Lauque D, Charpentier S. Levocetirizine and prednisone are not superior to levocetirizine alone for the treatment of acute urticaria: a randomized double-blind clinical trial. Ann Emerg Med. 2018;71(1):125–131.e1.CrossRefPubMedGoogle Scholar
  23. 23.
    Solensky R, Khan DA, Bernstein IL, Bloomberg GR, Castells MC, Mendelson LM, et al. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105:259–73.CrossRefGoogle Scholar
  24. 24.
    Chovel-Sella A, Ben Tov A, Lahav E, Mor O, Rudich H, Paret G, Reif S. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics. 2013;131:1424–7.CrossRefGoogle Scholar
  25. 25.
    Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes-Bavinck JN, Halevy S, et al. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol. 2013;133:1197–204.CrossRefPubMedGoogle Scholar
  26. 26.
    de Silva HA, Ryan NM, de Silva HJ. Adverse reactions to snake antivenom, and their prevention and treatment. Br J Clin Pharmacol. 2016;81:446–52.CrossRefPubMedGoogle Scholar
  27. 27.
    White AA, Stevenson DD, Woessner KM, Simon RA. Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies. Allergy Asthma Proc. 2013;34:138–42.CrossRefPubMedGoogle Scholar
  28. 28.
    Sogn DD, Evans R, Shepherd GM, et al. Results of the National Institute of Allergy and Infectious Diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Ann Intern Med. 1992;152:1025–32.CrossRefGoogle Scholar
  29. 29.
    Gadde J, Spence M, Wheeler B, et al. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA. 1993;270:2456–63.CrossRefPubMedGoogle Scholar
  30. 30.
    Dorman SM, Seth S, Khan DA. Risk of allergic reactions to recurrent intravenous penicillin administration in penicillin skin test negative patients. J Allergy Clin Immunol Pract. 2018;6(1):196–200.CrossRefPubMedGoogle Scholar
  31. 31.
    Macy E, Khan DA, Castells MC, Lang DM. Penicillin allergy testing: a key component of antibiotic stewardship. Clin Infect Dis. 2017;64(4):531–2.PubMedGoogle Scholar
  32. 32.
    Wulf NR, Matuszewski KA. Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity? Am J Health Syst Pharm. 2013;70:1483–94.CrossRefPubMedGoogle Scholar
  33. 33.
    Romano A, Gueant-Rodriguez RM, Viola M, et al. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med. 2004;141:16–22.CrossRefPubMedGoogle Scholar
  34. 34.
    Jeffrey Modell Foundation. [Internet]. 10 Warning signs [cited 2017 Sept 21]. Available from: http://www.info4pi.org/library/educational-materials/10-warning-signs.
  35. 35.
    Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136:1186–205.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Allergy and ImmunologyCleveland Clinic Lerner College of Medicine, Cleveland Clinic Children’s HospitalClevelandUSA

Personalised recommendations